Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACAD | AMGN | BMY | VRTX | GILD |
| Company | Acadia Pharmaceutica | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 16.25 | 289.00 | 57.98 | 452.44 | 88.80 |
| High | 16.39 | 289.00 | 57.98 | 452.44 | 88.80 |
| Low | 16.05 | 289.00 | 57.98 | 452.44 | 88.80 |
| Last | 16.27 | 289.00 | 57.98 | 452.44 | 88.80 |
| Change | +0.06 | +1.13 | +0.10 | +1.21 | +0.17 |
| % Change | +0.37% | +0.39% | +0.17% | +0.27% | +0.19% |
| Volume | 1,087,200 | 3,145 | 5,583 | 544 | 3,016 |
| 20-Day Average Volume | 1,444,420 | 2,745,352 | 12,026,584 | 1,270,427 | 7,326,421 |
| Previous Close | 16.21 | 287.87 | 57.88 | 451.23 | 88.63 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 15.99 | 307.37 | 55.91 | 479.34 | 90.84 |
| 20-Day Raw Stochastic | 45.17% | 25.51% | 66.56% | 9.47% | 21.22% |
| 20-Day Relative Strength | 52.43% | 35.78% | 60.15% | 41.60% | 51.44% |
| Weighted Alpha | -31.16 | +1.49 | +25.31 | +18.82 | +24.21 |
| Today's Opinion | 8% Sell | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Previous Opinion | 24% Sell | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Last Month's Opinion | 100% Sell | 8% Buy | 88% Buy | 8% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.50% since 11/13/24 | -2.34% since 11/14/24 | -0.89% since 11/14/24 | -6.51% since 11/14/24 | -3.59% since 11/14/24 |
| Low | 16.05 on 11/19/24 | 275.56 on 11/19/24 | 55.82 on 11/15/24 | 445.38 on 11/20/24 | 86.08 on 11/19/24 |
| High | 17.77 on 11/14/24 | 291.50 on 11/15/24 | 58.83 on 11/20/24 | 479.93 on 11/15/24 | 91.99 on 11/15/24 |
| 1-Month | |||||
| %Chg | +6.34% since 10/18/24 | -8.76% since 10/21/24 | +11.24% since 10/21/24 | -5.37% since 10/21/24 | +2.91% since 10/21/24 |
| Low | 14.15 on 10/23/24 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 445.38 on 11/20/24 | 85.60 on 10/22/24 |
| High | 18.71 on 11/11/24 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | +4.50% since 08/20/24 | -12.20% since 08/21/24 | +19.69% since 08/21/24 | -6.93% since 08/21/24 | +18.20% since 08/21/24 |
| Low | 14.15 on 10/23/24 | 275.56 on 11/19/24 | 46.88 on 08/22/24 | 445.38 on 11/20/24 | 75.35 on 08/22/24 |
| High | 18.71 on 11/11/24 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +7.75% since 05/20/24 | -8.21% since 05/21/24 | +37.17% since 05/21/24 | +2.36% since 05/21/24 | +31.97% since 05/21/24 |
| Low | 14.15 on 10/23/24 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 19.44 on 07/31/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,707,198 | 154,739,632 | 117,390,888 | 116,204,808 | 110,456,552 |
| Shares Outstanding, K | 166,392 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 726,440,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -61,290,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 250,400,000 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | 32,770,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 0.38 | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.20 on 11/06/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/06/24 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 20.78 | 14.57 | 49.77 | 0.00 | 19.81 |